Graham P. Taylor

Norfolk Place
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 261 publications

Timing of Loss of Transplacental Antibodies in Infants Born to Mothers Living With Human T-cell Lymphotropic Virus Type 1.

Timing of Loss of Transplacental Antibodies in Infants Born to Mothers Living With Human T-cell Lymphotropic Virus Type 1.

Journal: The Pediatric infectious disease journal
Published: August 13, 2026

Emergence of West African Human T-Lymphotropic Virus 1aC Subgroup, Brazilian Amazon.

Emergence of West African Human T-Lymphotropic Virus 1aC Subgroup, Brazilian Amazon.

Journal: Emerging infectious diseases
Published: June 28, 2026

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Journal: Expert review of anti-infective therapy
Published: June 25, 2026

Microbiological factors in the design, validation and verification of operating theatre ventilation: Healthcare Infection Society consensus guidance for infection prevention and control professionals, and members of ventilation safety groups.

Microbiological factors in the design, validation and verification of operating theatre ventilation: Healthcare Infection Society consensus guidance for infection prevention and control professionals, and members of ventilation safety groups.

Journal: The Journal of hospital infection
Published: April 24, 2026

HTLV-1 genetic diversity of 52 complete sequences from 14 African countries reveals novel variants and a lack of typical P12/P8 and P30 accessory proteins in HTLV-1b, d, and f genotypes.

HTLV-1 genetic diversity of 52 complete sequences from 14 African countries reveals novel variants and a lack of typical P12/P8 and P30 accessory proteins in HTLV-1b, d, and f genotypes.

Journal: Emerging microbes & infections
Published: March 25, 2026

Full blood count dynamics in immunologically naïve individuals with mild COVID-19: A prospective community cohort study.

Full blood count dynamics in immunologically naïve individuals with mild COVID-19: A prospective community cohort study.

Journal: PloS one
Published: March 09, 2026

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

Loss of HTLV-1-specific CD8+ T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma.

Loss of HTLV-1-specific CD8+ T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma.

Journal: Blood neoplasia
Published: December 24, 2025

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV
Published: December 09, 2025

Human T-cell lymphotropic virus type 1.

Human T-cell lymphotropic virus type 1.

Journal: Sexually transmitted infections
Published: October 16, 2025

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy.

Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy.

Journal: AIDS (London, England)
Published: October 13, 2025
Showing 1-12 of 261

Last Updated: 09/26/2026